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1. 1. The object of research
The object of research is women in whom the risk of osteoporotic fractures was assessed 
using the FRAX, Q-Fracture algorithms, and the risk factors for osteoporosis and their role in the 
development of osteoporotic fractures were studied.
1. 2. Problem statement
Osteoporosis (from the Greek “ostéon” – bone and “póros” – hole, pore) is a systemic dis-
ease of the skeleton, characterized by a decrease in bone tissue mass, disruption of bone microar-
chitectonics, which leads to increased fragility of bones and an increased risk of fractures (WHO, 
1993). With the increase in life expectancy, osteoporosis (OP) is becoming one of the main causes 
of health loss and death, both among women and men. According to the National Osteoporosis 
Foundation, (2016), 9 million fractures occur annually worldwide due to osteoporosis. From 200, 
million women worldwide, osteoporosis is diagnosed: up to 60 years in every tenth woman, at 
70 years in every fifth woman, in two out of five at the age of 80 and after 90 years it is diagnosed 
in two out of three [1]. The prevalence of OP in the EU countries was estimated at 27.6 million. In 
2013, in men over the age of 50, the prevalence of OP ranges from 5.9 % (Poland) to 7.2 % (Lux-
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embourg). For women, rates vary from 19.1 % (Cyprus) to 23.5 % (France). The economic burden 
of these incidents was estimated at 37 billion EUR. Fractures accounted for 66 % of this cost, long-
term fracture treatment 29 %, and pharmacological prophylaxis 5 %. Expenditures are expected 
to increase by 25 % until 2025. [2] In Ukraine, osteoporosis is detected in 13.4 % of the female 
population, and with age, the number of sick women increases to 53 % [3].
In terms of importance, OP is one of the leading chronic non-infectious diseases, second 
only to cardiovascular, oncological and endocrine diseases [4]. OP is common in the practice of 
a family doctor, but doctors perceive OP as a low priority issue and highlight a lack of awareness 
of the condition. Therefore, there is growing attention to the study of risk factors for osteoporosis, 
according to their role in the development of osteoporotic fractures. Osteoporosis is a heteroge-
neous multifactorial disease, in the development of which risk factors and their combinations play 
an important role. So, the main risk factors for fractures are considered age after 65 years, female 
sex, family history of fractures, tendency to falls, prolonged use of glucocorticoids, alcohol abuse 
and the presence of certain somatic diseases, in particular cardiovascular diseases, type II diabetes 
mellitus, rheumatoid arthritis and others [5, 6].
It is known that osteoporosis is clinically manifested by fractures. But for a long time, the 
disease is asymptomatic, any manifestations may be absent. The data indicate not only a tendency 
towards an increase in the incidence of OP, but also a steady increase in the number of osteoporotic 
fractures (OPF), which is the main clinical outcome of the disease, significantly affecting the eco-
nomic costs of society, increasing disability and mortality among the population [7].
1. 3. Suggested solution to the problem
Ideally, clinical assessment should take into account all determinants of fracture risk, but 
nowadays, bone mass assessment is the only aspect that can be easily measured in clinical practice, 
used for diagnosis, treatment, risk prediction and monitoring of patients undergoing treatment. The 
diagnostic criterion for OP is based on the measurement of BMD – the amount of bone mass per 
unit volume (bulk density, g/cm3) or per unit area (g/cm2). Both indicators can be measured in vivo 
using various densitometric methods [8, 9] The reference standard for diagnosing OP is dual-en-
ergy X-ray densitometry (DXA), but this technique has significant drawbacks (inability to obtain 
a three-dimensional image or information about bone microstructure), resulting in insufficient 
diagnosis of the disease. In addition, total screening for BMD abnormalities is not advisable, since 
it would exceed 2–10 times the cost of treating all potential OPFs [10].
Ultrasound densitometry has established itself as a screening method for osteoporosis, 
which makes it possible to early identify persons at risk and promptly direct them for dual-en-
ergy X-ray absorptiometry (DXA). This is a safe diagnostic method, because it does not use 
ionizing radiation, the devices are portable, which makes it easy to implement in primary health 
care. Thus, recent studies highlight that quantitative ultrasonography of the calcaneus can pre-
dict fractures as effectively as dual-energy X-ray absorptiometry in postmenopausal women and 
men [11, 12].
A family doctor has the ability to assess the risk of osteoporotic fractures using the FRAX 
and Q-Fracture questionnaires, even without using BMD, which significantly increases the diag-
nosis of the disease. FRAX® Algorithm - widely used to assess the 10-year likelihood of major 
osteoporotic and femoral fractures. Today, FRAX algorithms are available for 64 countries where 
the epidemiology of fractures is known, in 31 languages, covering more than 80 % of the world 
population, including in 16 of the 27 EU member states [13, 14]. Austria, Belgium, Denmark, Fin-
land, Hungary and the United Kingdom have the highest rates of FRAX use. In many best practice 
guidelines (e.g. in the UK) the use of FRAX should be ahead of the use of DXA [15].
Based on a mathematical analysis of the existing risk factors for osteoporosis, the algo-
rithm calculates the 10-year probability of a femur fracture (FRAX Hip) and other typical fractures 
(FRAX Total) associated with OP. FRAX Total includes fractures of the humerus, femur, radius, 
clinically significant fractures of the vertebral bodies, both with BMD data and without BMD 
(T-score) in women over 40 years of age [16, 17]. The Q Fracture algorithm calculates the risk of 
fracture from 1 to 10 years, contains an extended list of questions about the presence of chronic 
non-communicable diseases, and data on the risk of falling [18] Data obtained using the algorithms 
are presented in percentages.
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The influence of each factor can be very variable and depends not only on the population, 
but also on the region of the country, prompting a deeper study of this issue.
The aim of this research is to identify risk factors for osteoporosis in women of different 
age groups and to calculate the fracture risk using the Frax and Q Fracture algorithm in women 
over 40 years of age.
2. Materials and methods of research
The study was carried out on the basis of the Department of General Practice (Family Med-
icine) of the Bogomolets National Medical University in 2019.
The study was agreed at a meeting of the Commission on Bioethical Expertise and Ethics 
of Scientific Research at the Bogomolets National Medical University No. 127 dated 12.02.2019. 
The study does not pose an increased risk to research subjects and is carried out in accordance with 
existing bioethical norms and scientific standards in accordance with the requirements of Good 
Clinical Practice (ICH GCP) and the Declaration of Helsinki.
There was a survey of 35 women in the Odessa region of Ukraine, whose average age was 
54.1±11.8 years (minimum – 31; median – 55; maximum – 77). All women were divided by age into 
groups at ten-year intervals.
The structural and functional state of the bone tissue was assessed using a Hitachi AOS-
100E EggQus ultrasonic densitometer (Hitachi Medical Systems Singapore, Singapore) on the heel 
bone. SOS (velocity of ultrasound transmission, in m/s), TI (transmission index), OSI (bone ultra-
sound index), Z-score indices (comparison with the average norm in a given age group) and T-score 
(comparison with the norm for a middle-aged adult with “peak” bone mass). Changes in the struc-
ture of bone tissue were recorded in accordance with the established WHO criteria (1994) accord-
ing to the T-score of bone mineral density (BMD) were examined were divided into groups: T score 
from +2.5 to –1 – normal; from –1.5 to –2.5 osteopenia; from –2.5 and below – osteoporosis [4].
The fracture risk was calculated using online calculators FRAX and Q Fracture in women 
over 40 years of age [10, 12].
Anthropometric examination included determination of body weight and height. BMI was 
calculated according to the generally accepted formula.
Inclusion criteria: signed informed consent of the patient to participate in the study, female, 
age from 30 to 80 years.
Exclusion criteria: type 1 diabetes mellitus; exacerbation of chronic non-communicable 
diseases and diseases in the stage of decompensation; persons with oncological diseases; taking 
medications that can affect bone metabolism; pregnancy and lactation.
Statistical processing of the results was carried out using the statistical program “Statistica 
10.0”. Descriptive statistics are presented as arithmetic mean and standard deviation. Comparison 
of parameters in the study groups was carried out using the Student’s test. To study the nature and 
strength of the relationship between the studied indicators, we used the Pearson or Spearman cor-
relation coefficient, depending on the nature of the data distribution. Differences were considered 
statistically significant at p<0.05.
3. Results
We examined 35 women in the Odesa region, whose average age was 54.1±11.8 years. The num-
ber of middle-aged and elderly women was 77.1 %. Moreover, most of them were aged 51–70 years. The 
average indicators of weight, height and BMI of all women included in the study are shown in Table 1.
The structure of concomitant pathology was dominated by diseases of the circulatory system – 
16 cases (45.7 %) and of the digestive system – 11 (31.4 %).
The following risk factors for osteoporosis have been identified.
Smoking at the time of the survey was confirmed by 3 women (8.6 %), and one smoked in 
the past (2.8 %). All surveyed women denied alcohol abuse. Five respondents (14.3 %) suffered 
fractures of bones of various localization, and 13 respondents (37.1 %) reported fractures of the 
femur or signs of osteoporosis in their parents; four women noted a decrease in height after 40 years 
(13.3 % among those surveyed over 40). Periods of amenorrhea were diagnosed in 3 people (8.6 %); 
the onset of menopause before the age of 45 was confirmed in 4 respondents (11.4 %). Three women 
(8.6 %) have taken corticosteroids in the past and one (2.8 %) is taking antidepressants. Insufficient 
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consumption of dairy products was found in 16 women (45.7 %). Reduced physical activity was 
confirmed by 24 people (68.6 %).
Table 1








Note: data are presented as M±SD, BMI – body mass index, Z-score, T-score – indicators of ultrasound densitometry
Pre- and postmenopausal women were categorized by age. The lowest BMD indices were 
found at the age of 70–79 years: –1.96±0.5 (p<0.004), and the largest number of women with osteo-
penic changes was found in the group of 50–59 years.
Osteopenic changes in the bones in women after 40 years were assessed by the T-score, ac-
cording to the WHO recommendations. A decrease in BMD was diagnosed in 16 women (51.6 %) 
after 40 years. In young women (n=4), bone density was assessed with a Z-score. Ostepenic chang-
es were found in 2 respondents, the rest had normal BMD.
The 10-year risk of osteoporotic fractures was assessed with and without BMD using the 
FRAX, Q-fracture algorithms. The data obtained are presented in Table 2.
Table 2
Ratio of BMD and Q-fracture, FRAX algorithms with and without BMD in women after 40 years
Algorithm metrics/Diseases Norm (n=15) Osteopenia (n=15) Osteoporosis (n=1) Р
FRAX Total, % 5.58±4.9 6.14±2.5 11 0.044
FRAX Hir, % 0.2±0.1 1.56±2.0 4.1 0.001
FRAX Total without BMD, % 6.8±5.98 7.92±5.3 9 0.026
FRAX Hir without BMD, % 1.16±1.8 2.4±3.5 2.7 0.087 
Q-fracture Total, % 3.55±1.4 7.76±4.86 10.8 0.004
Q-fracture Hір, % 0.59±0.4 2.9±3.31 7.8 0.004
T-score –0.35±0.4 –1.52±0.34 –2.68 0.001
Z-score 0.38±0.5 –0.35±0.6 –1.36 0.003
Note: data are presented as M±SD, Z-score, T-score – indicators of ultrasonic densitometry
The risk of fractures according to all algorithms was higher in women in the 70–79 age 
group: FRAX Total – 8.87±3.2, FRAX Hip – 4.03±3.1, Q fracture total – 12.87±1.5, Q fracture 
Hip –7.97±2.7, FRAX Total without BMD – 11.9±5.5, FRAX Hip without BMD - 6.3±4.8. Signif-
icant differences were found according to the Q-fracture Total, Q-fracture Hir FRAX Hip, FRAX 
Hir without BMD p <0.01. The data are presented in Table 3.
Table 3
Relationship between algorithms and age in women after 40 years
Algorithm indicators/Age groups, years All women (n=31) 40-49 (n=5) 50–59 (n=16) 60–69 (n=6) 70–79 (n=4)
FRAX Total, % 6.02±3.98 4.76±1.7 6.23±4.6 4.65±2.6 8.87±3.2
FRAX Hір, % 0.99±1.7 0.4±0.6* 0.41±0.3# 1±0.8 & 4.03±3.1*,#, &
FRAX Total without BMD, % 7.41±5.6 4.08±1.2 6.56±5.3 9.48±5.9 11.9±5.5
FRAX Hір without BMD, % 1.81±2.8 0.24±0.1* 0.86±0.9# 2.68±2.3* 6.3±4.8*,#
Q-fracture Total, % 5.82±4.1 2±0.7* 4.33±1.5# 8.28±5*,# 12.87±1.5*,#
Q-fracture Hір, % 1.94±2.8 0.18±0.1* 0.72±0.4 # 2.63±1.9*, & 7.97±2.7*, #, &
Note: * – р<0.01 reliability between the age groups 40–49 and 50–59, 60–69 years; # – р<0.01 reliability between the age groups 
70–79 and 50–59, 60–69 years; & – р<0.01 reliability between the age groups 60–69 and 70–79 years
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Correlation analysis of BMD and the risk of fractures revealed a negative correlation be-
tween T score with FRAX Total with BMD (r=–0.45, p=0.01), FRAX Hip with BMD (r=–0.89, 
p=0.008) , Q fracture total (r=–0.46, p=0.007), Q fracture Hip (r=–0.51, p=0.008), positive rela-
tionship with Z score (r=0.74, p=0.0005 ).
It was revealed that FRAX Total without BMD is positively correlated with Q fracture total 
(r=0.55, p=0.001), with FRAX Total with BMD (r=0.66, p=0.004).
Age correlates negatively with the T score (r=–0.47, p=0.007) and positively with the 
FRAX Total algorithms without BMD (r=–0.47, p=0.003), FRAX Hip without BMD (r=0.78, 
p=0.006), Q fracture total (r=0.86, p=0.007), Q fracture Hip (r=0.92, p=0.008), FRAX Hip with 
BMD (r=0.55, p=0.009) ... No statistically significant difference was found with FRAX Total 
with BMD (r=0.21, p=0.345).
4. Discussion
Not all countries accept DXA as the only criterion, since BMD has high specificity, but low 
sensitivity (30–50 %) – most OPFs will occur in individuals with osteopenia or with BMD values 
above the osteoporosis threshold. Low sensitivity was the main reason not to recommend BMD test-
ing for population screening [14]. Fracture risk assessment is improved by simultaneously considering 
risk factors that operate independently of BMD [19]. A survey was carried out on a small group of 
women. But we were able to quickly collect data in a fairly short period of time and clearly demon-
strate how osteoporosis screening can be organized in the practice of a family doctor. The results 
obtained proved that the algorithms are informative and useful even without densitometry data.
The advantages of using algorithms for assessing the 10-year risk of fractures are that they 
are available (online versions), they are non-value and do not require the experience that is required 
to perform densitometry. Can be used in rural outpatient clinics to identify individuals at risk of 
developing OPFs, to determine the need to start osteoporotic therapy or to prescribe DXA. The 
use of FRAX is more widespread, the advantage of this model is the availability of the Ukrainian 
version and the possibility of using both with densitometry indicators and without these indicators. 
The Q fracture algorithm uses English, but it is possible to assess the risk of fracture from one year 
and contains an extended list of questions about the presence of comorbidities.
It was determined that the question of smoking at the present time, a decrease in growth after 45 
years, the presence of fractures in the history of life and in parents, early menopause (up to 45 years), 
insufficient physical activity is highly informative and helps in the diagnosis of osteoporosis.
Study limitation. A thorough history taking is required. The patient, in order to be included 
in the examination, should not receive anti-osteoporotic therapy. To calculate the risk of fractures, the 
age must be at least 40 years for the FRAX algorithm, and more than 30 years for the Q fracture. In 
general, this study is safe, ultrasound densitometry can be used in both children and pregnant women.
Prospects for further research. The problem of early identification of persons at high 
risk of osteoporotic fractures remains open. This issue requires a more detailed study not only in 
relation to age, but also in relation to the region of the country and the conditions in which the re-
spondents find themselves. Ultrasound densitometry in combination with algorithms for assessing 
the risk of osteoporotic fractures can be used in epidemiological studies.
5. Conclusions
1. A significant increase in the risk of osteoportic fractures in women with reduced BMD is 
found according to all algorithms (except for FRAX Hir without BMD) and the greatest risk was 
at the age of 70–79 years. Age significantly affects BMD indicators; the greatest decrease in bone 
density was diagnosed in postmenopausal women. At the same time, only half of women in the age 
group 30–39 years had normal BMD indices, this fact requires detailed study.
2. At the same time, there is a proportional increase in the number and severity of intercur-
rent diseases in accordance with age and is the highest in the older age groups of patients.
3. In postmenopausal women, ultrasound densitometry is an informative method for assessing 
the structural and functional state of bone tissue. And the combination with algorithms for assessing 
the 10-year risk of osteoporotic fractures significantly increases the early diagnosis of osteoporosis.
4. Algorithms FRAX and Q fracture can be recommended for use by a family doctor to predict 
the occurrence of osteoporotic fractures and timely identify risk factors associated with osteoporosis, 
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even without using the BMD indicator. These are affordable and high-speed methods for assessing the 
10-year risk of osteoporotic fractures, which will be useful for planning preventive measures for osteo-
porosis and its complications, as well as for the next diagnostic steps for early detection of the disease.
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